Epigenetic Modifications of Diabetes Mellitus Type I
NCT01623388 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2014-01-09
Summary
This research is being done to find out if significant changes in blood glucose cause bad outcomes in patients with diabetes.
Conditions
- Type I Diabetes
Interventions
- PROCEDURE
-
Oral glucose tolerance test for Phase I
Oral glucose tolerance test for Diabetic patients in phase I
Sponsors & Collaborators
-
Scripps Translational Science Institute
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2014-01-31
Countries
- United States
Study Locations
More Related Trials
-
DNA Methylation and Gene Expression in Qataris With Type 2 Diabetes
NCT02021695 ·Status: COMPLETED
-
Changes in Arterial Stiffness and Endothelial Glycocalyx in Patients With Poorly Controlled Diabetes Mellitus Type 1 or Type 2 After Optimization of Antidiabetic Medication.
NCT03010956 ·Status: COMPLETED
-
Common Genetic Variation and Type 2 Diabetes
NCT00707616 ·Status: COMPLETED
-
Evaluation of Biomarker Expression in Diabetic and Healthy Subjects Over a One Year Period
NCT01900834 ·Status: COMPLETED
-
Heterogeneity of Diabetes: Integrated Muli-Omics to Identify Physiologic Subphenotypes and Evaluate Targeted Prevention
NCT06682351 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Molecular and Clinical Profile of Diabetes Mellitus and Its Complications
NCT01105858 ·Status: SUSPENDED
-
Incretin Based Therapy for Poorly Controlled Type 2 Diabetic Patients
NCT02026024 ·Status: COMPLETED
-
The Genetics of Diabetes in Southern California Chinese Americans
NCT00824395 ·Status: WITHDRAWN
-
Uncovering the 'ORIGINS' of Diabetes
NCT02226640 ·Status: COMPLETED
-
Mechanisms of Pro-Thrombosis in Diabetes Mellitus -- Ancillary to BARI 2D
NCT00041405 ·Status: COMPLETED
-
Mitochondrial DNA Copy Number and Leukocyte Telomere Length as Biomarkers in Type 2 Diabetic Patients
NCT05684406 ·Status: UNKNOWN
-
Clinical Verification of Peptide Biomarkers for Type 2 Diabetes Mellitus
NCT01902316 ·Status: COMPLETED
-
Gene Expression Profiling and Bioinformatic Analysis Identifying Genes and Biochemical Pathways in Type 2 Diabetes
NCT00143013 ·Status: UNKNOWN
-
Arginase Inhibition in Type 1 and Type 2 Diabetes Mellitus
NCT05806502 ·Status: COMPLETED ·Phase: NA
-
Salivary Transcriptome Biomarkers for Early Diabetes Detection
NCT02673762 ·Status: UNKNOWN
-
Metagenomic Analysis of Human Gut Microbiota in Patients With Metabolic Diseases Including Diabetes
NCT03204799 ·Status: UNKNOWN
-
A Study of Blood Metabolic Markers in Patients With Type 2 Diabetes Mellitus of Different Stages
NCT06155539 ·Status: NOT_YET_RECRUITING
-
Cohort Study of Patients With Type 1 Diabetes
NCT03610984 ·Status: COMPLETED
-
Clinical Characteristics of People With Long-term Type 1 Diabetes
NCT05359796 ·Status: RECRUITING
-
Natural History of Autoimmune Diabetes and Its Complications
NCT00896610 ·Status: TERMINATED
-
Optimized Diagnosis and Precision Medicine of MODY
NCT06111833 ·Status: RECRUITING
-
Study of the Genome, Gut Metagenome and Lifestyle of Patients With Incident Type 2 Diabetes Mellitus
NCT04113239 ·Status: COMPLETED
-
A Prospective Cohort Study for Establishing Clinical Excellence in Patients With Newly Diagnosed Type 1 and Type 2 Diabetes and Prediabetes
NCT05401708 ·Status: NOT_YET_RECRUITING
-
Diabetic Cardiovascular Complications: Multi-Omics Analysis
NCT06824233 ·Status: NOT_YET_RECRUITING
-
Precise Treatment of Prediabetes and Stage 1 Hypertension
NCT04529590 ·Status: COMPLETED